Teladoc Health (NYSE:TDOC) Stock Price Expected to Rise, Barclays Analyst Says

Teladoc Health (NYSE:TDOC) had its price target upped by Barclays from $10.00 to $12.00 in a report issued on Thursday, Benzinga reports. Barclays currently has an overweight rating on the health services provider’s stock.

A number of other research firms also recently commented on TDOC. Royal Bank of Canada upped their price objective on shares of Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a research note on Wednesday, October 9th. Jefferies Financial Group upped their price target on shares of Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a research report on Tuesday, September 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $10.00 price target on shares of Teladoc Health in a report on Tuesday, August 20th. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a report on Thursday, August 1st. Finally, Truist Financial cut their target price on Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a research report on Friday, August 2nd. Fourteen equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $11.97.

Teladoc Health Stock Performance

Shares of TDOC opened at $9.21 on Thursday. Teladoc Health has a 1 year low of $6.76 and a 1 year high of $22.54. The company’s 50 day simple moving average is $8.48 and its 200 day simple moving average is $9.66. The company has a market capitalization of $1.58 billion, a price-to-earnings ratio of -1.60 and a beta of 0.90. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.10. The company had revenue of $640.51 million for the quarter, compared to analyst estimates of $630.50 million. Teladoc Health had a negative return on equity of 9.40% and a negative net margin of 37.91%. On average, sell-side analysts predict that Teladoc Health will post -1.18 EPS for the current year.

Insiders Place Their Bets

In other news, CFO Mala Murthy sold 8,750 shares of Teladoc Health stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $7.16, for a total transaction of $62,650.00. Following the sale, the chief financial officer now directly owns 85,767 shares of the company’s stock, valued at approximately $614,091.72. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Thomas Mckinley purchased 4,000 shares of the firm’s stock in a transaction dated Thursday, September 12th. The stock was acquired at an average price of $7.69 per share, with a total value of $30,760.00. Following the completion of the transaction, the director now owns 39,077 shares of the company’s stock, valued at $300,502.13. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Mala Murthy sold 8,750 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total transaction of $62,650.00. Following the completion of the sale, the chief financial officer now directly owns 85,767 shares in the company, valued at $614,091.72. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 35,051 shares of company stock worth $257,565 in the last quarter. 0.95% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently modified their holdings of TDOC. Allspring Global Investments Holdings LLC increased its holdings in Teladoc Health by 74.0% in the first quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider’s stock valued at $311,000 after buying an additional 8,750 shares during the last quarter. Principal Financial Group Inc. raised its position in shares of Teladoc Health by 33.1% during the 1st quarter. Principal Financial Group Inc. now owns 13,833 shares of the health services provider’s stock valued at $209,000 after acquiring an additional 3,442 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in Teladoc Health by 40.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 209,689 shares of the health services provider’s stock worth $3,166,000 after purchasing an additional 60,780 shares during the last quarter. Janney Montgomery Scott LLC boosted its holdings in Teladoc Health by 188.7% in the first quarter. Janney Montgomery Scott LLC now owns 31,594 shares of the health services provider’s stock worth $477,000 after purchasing an additional 20,651 shares during the period. Finally, Capstone Investment Advisors LLC increased its stake in Teladoc Health by 44.8% during the first quarter. Capstone Investment Advisors LLC now owns 32,196 shares of the health services provider’s stock valued at $486,000 after purchasing an additional 9,968 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.